We extend a heartfelt invitation to you for the 5th International Conference on Lymphocyte Engineering (ICLE), a pivotal event that will unfold from 20th to 22nd February 2025 in the vibrant city of Munich, Germany.
Lymphocyte engineering has dramatically transformed, advancing treatments for cancer, autoimmune diseases, infectious diseases, and immune deficiencies. This field has grown through the integration of gene, cell, and immune therapies, utilizing technologies like vectorology, genome editing, in-vivo engineering, and precision protein design. Such advancements and regulatory approvals highlight its crucial role in medical innovation.
ICLE 2025 promises an exciting lineup featuring Dr. Drew Weissman, 2023 Nobel Laureate and co-inventor of modified mRNA technology, alongside pioneers Dr. Carl June and Dr. Michel Sadelain in CAR T clinical translation. This event is designed to foster knowledge exchange, collaboration, and advancements in clinical applications, enhancing the impact of lymphocyte engineering.
Join us for a groundbreaking conference where the global scientific community will engage in three days of intensive learning, case studies, and networking, contributing to a mission that shapes the future of medicine through shared expertise and collaborative
...
afficher plus
We extend a heartfelt invitation to you for the 5th International Conference on Lymphocyte Engineering (ICLE), a pivotal event that will unfold from 20th to 22nd February 2025 in the vibrant city of Munich, Germany.
Lymphocyte engineering has dramatically transformed, advancing treatments for cancer, autoimmune diseases, infectious diseases, and immune deficiencies. This field has grown through the integration of gene, cell, and immune therapies, utilizing technologies like vectorology, genome editing, in-vivo engineering, and precision protein design. Such advancements and regulatory approvals highlight its crucial role in medical innovation.
ICLE 2025 promises an exciting lineup featuring Dr. Drew Weissman, 2023 Nobel Laureate and co-inventor of modified mRNA technology, alongside pioneers Dr. Carl June and Dr. Michel Sadelain in CAR T clinical translation. This event is designed to foster knowledge exchange, collaboration, and advancements in clinical applications, enhancing the impact of lymphocyte engineering.
Join us for a groundbreaking conference where the global scientific community will engage in three days of intensive learning, case studies, and networking, contributing to a mission that shapes the future of medicine through shared expertise and collaborative effort.
Abstract Submission Deadline: 17 September 2024
Early Bird Registration Deadline: 30 October 2024
URLs:
LinkedIn: https://go.evvnt.com/2419544-5?pid=1356
YouTube: https://go.evvnt.com/2419544-6?pid=1356
afficher moins
